ESAB Corporation (ESAB) Tops Q4 EPS by 8c ; Offers Guidance

ESAB Corporation (NYSE: ESAB) reported Q4 EPS of $1.13, $0.08 better than the analyst estimate of $1.05. Revenue for the quarter came in at $689.35 million versus the consensus estimate of $643.22 million.

GUIDANCE:

ESAB Corporation sees FY2024 EPS of $4.65-$4.85, versus the consensus of $4.81.

For earnings history and earnings-related data on ESAB Corporation (ESAB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c